Thermo Fisher Approves $5 Billion Share Buyback Program
Thermo Fisher Scientific announced that its board of directors has approved a new $5 billion share repurchase program. Under this program, the company may repurchase its own shares depending on market conditions.
Share buyback programs are among the strategies companies use to manage their capital structure and enhance shareholder value. Thermo Fisher's move aims to support earnings per share by utilizing its existing cash position and financial flexibility.
The company stated that it will consider market conditions, share price, and other investment opportunities regarding the timing and amount of repurchases. The program has no expiration date and can be modified or terminated by the board of directors.
This decision was made within the framework of Thermo Fisher's long-term growth objectives and capital allocation policy. The company maintains a balanced approach to both organic growth and returning value to shareholders.
Not investment advice.
📊 TMO — Piyasa Yorumu
▲ up · 55%Thermo Fisher's approval of a $5 billion share buyback program signals confidence in the stock in the short term and could limit its downward trend. However, the technical picture is weak: the price is below the SMA20 and SMA50, the RSI at 34 is close to oversold territory, and the MACD is below its signal line. The buyback news could trigger a short-term relief rally, but additional confirmation is needed for a trend reversal. Therefore, I assess the impact as moderately positive; a sharp rally should not be expected.
RSI 14
34.1
MACD
-1.50
24h Δ
-0.62%
Canlı Grafikler
🔗 İlgili haberler
⭐ 65 · 10.08
Thermo Fisher, Hindistan'da Biyofarma Araştırma ve Üretim Artışıyla Müşteri Büyümesini Hedefliyor
⭐ 63 · 05.05
Thermo Fisher, Mikrobiyoloji İşini Astorg'a 1 Milyar Dolara Satıyor
⭐ 70 · 05.05
Thermo Fisher, mikrobiyoloji birimini 1 milyar doların üzerinde satıyor
⭐ 67 · 29.04
Thermo Fisher, Laboratuvar Ürünleri ve Biyofarma Hizmetleriyle Beklentileri Aştı
🧬 Buna benzer
⭐ 63
Barrick Gold, 3 Milyar Dolarlık Hisse Geri Alım Programını Onayladı
⭐ 72
BAE Systems, Hisse Geri Alım Programının Üçüncü Dilimini Başlattı
⭐ 63
SB Energy, OpenAI Veri Merkezi Anlaşması İçin 5,5 Milyar Dolarlık Varant Teklif Etti
⭐ 68
AbbVie’nin yumurtalık kanseri ilacı denemede %62,7 yanıt oranı gösterdi
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.